Literature DB >> 25095974

MicroRNA-92 promotes gastric cancer cell proliferation and invasion through targeting FXR.

Jian-Hua Duan1, Long Fang.   

Abstract

MicroRNAs (miRNAs), a class of small noncoding RNAs, play critical roles in human carcinogenesis through downregulation of various target genes. In the present study, we found that miR-92 is upregulated in gastric cancer tissues compared with adjacent normal tissues. Interestingly, miR-92 expression is significantly associated with clinical characteristics of patients. Gain or loss-of-function in vitro experiments further show that miR-92 mimics significantly promoted, while its antisense oligos inhibited gastric cancer cell proliferation and invasion. Moreover, luciferase reporter assays and western blot indicated that farnesoid X receptor (FXR), is a direct target of miR-92. Therefore, our data suggest that upregulation of miR-92 may represent an important mechanism for the development of gastric cancer.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25095974     DOI: 10.1007/s13277-014-2342-x

Source DB:  PubMed          Journal:  Tumour Biol        ISSN: 1010-4283


  26 in total

1.  Upregulation of microRNA-107 induces proliferation in human gastric cancer cells by targeting the transcription factor FOXO1.

Authors:  Fan Li; Baohua Liu; Yu Gao; Yuliang Liu; Yu Xu; Weidong Tong; Anping Zhang
Journal:  FEBS Lett       Date:  2013-12-25       Impact factor: 4.124

2.  Estrogen receptor {beta}1 expression is regulated by miR-92 in breast cancer.

Authors:  Hakeemah Al-Nakhle; Philip A Burns; Michele Cummings; Andrew M Hanby; Thomas A Hughes; Sampoorna Satheesha; Abeer M Shaaban; Laura Smith; Valerie Speirs
Journal:  Cancer Res       Date:  2010-05-18       Impact factor: 12.701

3.  MYCN-regulated miRNA-92 inhibits secretion of the tumor suppressor DICKKOPF-3 (DKK3) in neuroblastoma.

Authors:  Bjørn Helge Haug; Jørn R Henriksen; Jochen Buechner; Dirk Geerts; Ellen Tømte; Per Kogner; Tommy Martinsson; Trond Flægstad; Baldur Sveinbjørnsson; Christer Einvik
Journal:  Carcinogenesis       Date:  2011-05-13       Impact factor: 4.944

4.  The farnesoid X receptor is expressed in breast cancer and regulates apoptosis and aromatase expression.

Authors:  Karen E Swales; Márta Korbonits; Robert Carpenter; Desmond T Walsh; Timothy D Warner; David Bishop-Bailey
Journal:  Cancer Res       Date:  2006-10-15       Impact factor: 12.701

5.  Comparative epidemiology of gastric cancer between Japan and China.

Authors:  Yingsong Lin; Junko Ueda; Shogo Kikuchi; Yukari Totsuka; Wen-Qiang Wei; You-Lin Qiao; Manami Inoue
Journal:  World J Gastroenterol       Date:  2011-10-21       Impact factor: 5.742

6.  MicroRNA expression profiling of oral carcinoma identifies new markers of tumor progression.

Authors:  L Scapoli; A Palmieri; L Lo Muzio; F Pezzetti; C Rubini; A Girardi; F Farinella; M Mazzotta; F Carinci
Journal:  Int J Immunopathol Pharmacol       Date:  2010 Oct-Dec       Impact factor: 3.219

7.  Disrupted microRNA expression caused by Mecp2 loss in a mouse model of Rett syndrome.

Authors:  Rocio G Urdinguio; Agustin F Fernandez; Pilar Lopez-Nieva; Simona Rossi; Dori Huertas; Marta Kulis; Chang-Gong Liu; Carlo M Croce; George A Calin; Manel Esteller
Journal:  Epigenetics       Date:  2010-10-01       Impact factor: 4.528

8.  Farnesoid X receptor is essential for normal glucose homeostasis.

Authors:  Ke Ma; Pradip K Saha; Lawrence Chan; David D Moore
Journal:  J Clin Invest       Date:  2006-03-23       Impact factor: 14.808

9.  Synergistic growth inhibition of human hepatocellular carcinoma cells by acyclic retinoid and GW4064, a farnesoid X receptor ligand.

Authors:  Tomohiko Ohno; Yohei Shirakami; Masahito Shimizu; Masaya Kubota; Hiroyasu Sakai; Yoichi Yasuda; Takahiro Kochi; Hisashi Tsurumi; Hisataka Moriwaki
Journal:  Cancer Lett       Date:  2012-05-11       Impact factor: 8.679

10.  MicroRNA-92 regulates cervical tumorigenesis and its expression is upregulated by human papillomavirus-16 E6 in cervical cancer cells.

Authors:  Yu Yu; Yao Zhang; Shulan Zhang
Journal:  Oncol Lett       Date:  2013-06-17       Impact factor: 2.967

View more
  12 in total

1.  Role of microRNAs in diagnosis and treatment of the pathogenesis of gastric cancer.

Authors:  Gang Chen; Yong Tang; Jiang-Hua Wu; Feng-Hua Liu
Journal:  Int J Clin Exp Med       Date:  2014-12-15

2.  MiR-330-3p inhibits gastric cancer progression through targeting MSI1.

Authors:  Aoran Guan; Hui Wang; Xun Li; Hui Xie; Ruotian Wang; Yankun Zhu; Ruhong Li
Journal:  Am J Transl Res       Date:  2016-11-15       Impact factor: 4.060

3.  miR-448 suppressed gastric cancer proliferation and invasion by regulating ADAM10.

Authors:  Xuesong Wu; Haoran Tang; Guobin Liu; Hui Wang; Jie Shu; Feng Sun
Journal:  Tumour Biol       Date:  2016-02-08

4.  Evaluation of miR-720 prognostic significance in patients with colorectal cancer.

Authors:  Xu Wang; Yuting Kuang; Xiaochun Shen; Hao Zhou; Yan Chen; Ye Han; Bin Yuan; Jin Zhou; Hong Zhao; Qiaoming Zhi; Xiaofeng Xue
Journal:  Tumour Biol       Date:  2014-10-07

5.  Bile acids regulate intestinal cell proliferation by modulating EGFR and FXR signaling.

Authors:  Avafia Y Dossa; Oswaldo Escobar; Jamie Golden; Mark R Frey; Henri R Ford; Christopher P Gayer
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2015-11-25       Impact factor: 4.052

6.  Mechanistic Role of MicroRNAs in Coupling Lipid Metabolism and Atherosclerosis.

Authors:  Jan Novák; Veronika Olejníčková; Nikola Tkáčová; Gaetano Santulli
Journal:  Adv Exp Med Biol       Date:  2015       Impact factor: 2.622

7.  MiR-223 promotes the cisplatin resistance of human gastric cancer cells via regulating cell cycle by targeting FBXW7.

Authors:  Xiaoying Zhou; Wujuan Jin; Hongyan Jia; Jin Yan; Guoxin Zhang
Journal:  J Exp Clin Cancer Res       Date:  2015-03-26

Review 8.  Potential Diagnostic, Prognostic and Therapeutic Targets of MicroRNAs in Human Gastric Cancer.

Authors:  Ming-Ming Tsai; Chia-Siu Wang; Chung-Ying Tsai; Hsiang-Wei Huang; Hsiang-Cheng Chi; Yang-Hsiang Lin; Pei-Hsuan Lu; Kwang-Huei Lin
Journal:  Int J Mol Sci       Date:  2016-06-16       Impact factor: 5.923

9.  Decreased miR-503 expression in gastric cancer is inversely correlated with serum carcinoembryonic antigen and acts as a potential prognostic and diagnostic biomarker.

Authors:  Daoyi Wu; Gaojian Cao; Zhenfeng Huang; Kai Jin; Haowei Hu; Jie Yu; Yu Zeng
Journal:  Onco Targets Ther       Date:  2016-12-23       Impact factor: 4.147

10.  Activation of FXR promotes intestinal metaplasia of gastric cells via SHP-dependent upregulation of the expression of CDX2.

Authors:  Haining Zhou; Zhen Ni; Ting Li; Linna Su; Lianfeng Zhang; Na Liu; Yongquan Shi
Journal:  Oncol Lett       Date:  2018-03-23       Impact factor: 2.967

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.